Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 44.15M P/E - EPS this Y 53.50% Ern Qtrly Grth -
Income -40.32M Forward P/E -1.92 EPS next Y 22.30% 50D Avg Chg -2.00%
Sales 2.78M PEG - EPS past 5Y - 200D Avg Chg 6.00%
Dividend N/A Price/Book 1.74 EPS next 5Y - 52W High Chg -42.00%
Recommedations 1.70 Quick Ratio 4.97 Shares Outstanding 9.23M 52W Low Chg 131.00%
Insider Own 19.15% ROA -58.80% Shares Float 5.99M Beta 0.70
Inst Own 33.88% ROE -122.49% Shares Shorted/Prior 30.23K/26.23K Price 0.84
Gross Margin - Profit Margin - Avg. Volume 240,174 Target Price 12.75
Oper. Margin -3,876.95% Earnings Date Nov 12 Volume 14,557 Change 2.54%
About SAB Biotherapeutics, Inc.

SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders and infectious diseases. It has applied advanced genetic engineering and antibody science to develop transchromosomic bovine herds that produce fully human antibodies targeted at infectious diseases and immune and autoimmune disorders, including infectious diseases, influenza, CDI, type 1 diabetes, organ transplantation, and oncology, as well as immunology, gastroenterology, and respiratory diseases. The company also uses its DiversitAb immunotherapy platform to produce fully-human polyclonal antibodies without the need for human donors or plasma. In addition, its lead product candidate SAB-142, a human, multi-target anti-thymocyte globulin treatment, currently under Phase 1 trials in delaying the onset or progression of type 1 diabetes. Further, the company develops SAB-176, a multivalent, broadly neutralizing - human polyclonal immunoglobulin therapeutic candidate, currently in Phase 2a development for the treatment or prevention of severe influenza. SAB Biotherapeutics, Inc. was founded in 2014 and is headquartered in Miami Beach, Florida.

SAB Biotherapeutics, Inc. News
11/15/24 These 2 “Strong Buy” Penny Stocks Are Set to Triple (or more), Say Analysts
11/09/24 SAB Biotherapeutics Third Quarter 2024 Earnings: US$1.12 loss per share (vs US$0.97 loss in 3Q 2023)
11/06/24 SAB BIO Announces Third Quarter 2024 Financial Results and Provides Company Update
10/31/24 SAB BIO CEO to Participate in Fireside Chat at Guggenheim Securities Healthcare Innovation Conference
09/23/24 SAB Biotherapeutics (NASDAQ:SABS) Will Have To Spend Its Cash Wisely
09/13/24 SAB BIO CEO to Participate in Fireside Chat at 2024 Cantor Global Healthcare Conference
09/09/24 SAB BIO Provides SAB-142 Clinical Trial Progress Update at the European Association for the Study of Diabetes Annual Meeting
09/04/24 SAB BIO to Present at the European Association for the Study of Diabetes 60th Annual Meeting
08/08/24 SAB BIO Announces Second Quarter 2024 Financial Results and Provides Company Updates
08/05/24 SAB BIO Announces Founding of Clinical Advisory Board to Guide the Development of SAB-142 for Type 1 Diabetes
07/31/24 SAB BIO Appoints Lucy To as Chief Financial Officer
06/20/24 SAb Biotherapeutics Rebrands as SAB BIO
06/18/24 SAB Biotherapeutics to Present at the American Diabetes Association 84th Scientific Sessions
05/30/24 SAB Biotherapeutics Announces Departure of Chief Financial Officer
06:15 AM FDA Provides Clearance to IND Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics
05/20/24 SAB Biotherapeutics Announces Q1 2024 Financial Results and Provides Company Updates
05/06/24 SAB Biotherapeutics Appoints Jay Skyler, MD, to the Board of Directors
04/16/24 SAB Biotherapeutics Provides SAB-142 Trial Update
04/08/24 SAB Biotherapeutics to Present at INNODIA Annual Meeting
04/04/24 SAB Biotherapeutics to Present at the Needham Virtual Healthcare Conference
SABS Chatroom

User Image Nicks_pics Posted - 7 hours ago

$SABS Perhaps some sector rotation going on. Both my Bio's getting hit past few days. Volume and action has been unusal.

User Image Realtea03 Posted - 2 days ago

$SABS Wow this trade could make or break me. I created a strategy to buy shares/options that I think can go 10x or better. I figured I'd distribute this risk across at least 5-10 companies and as of right now I have had 4 of these hit and only 2 that went to 0. Each time I am successful I basically waterfall 20-30% back into either the companies I am most bullish on OR the companies that has been the most unfairly beaten down. Sooo needless to say I have been moving a lot of funds into this trade. I am hopeful we have positive news by year end, but if not I have certainly had my fair share of blessings this year. Cheers all!

User Image stockboyaisle1 Posted - 4 days ago

$SABS

User Image DDiamond_Handz Posted - 6 days ago

$SABS

User Image LuckyCs Posted - 1 week ago

$SABS Weekly Candlesticks 🧐

User Image TipRanks Posted - 1 week ago

These 2 “Strong Buy” Penny Stocks Are Set to Triple (or more), Say Analysts https://tipranks.com/news/article/these-2-strong-buy-penny-stocks-are-set-to-triple-or-more-say-analysts $GNLX $SABS -

User Image Stockness Posted - 1 week ago

$SABS This surely has to help. https://www.wsj.com/politics/policy/kristi-noem-trump-cabinet-homeland-security-703f42e9?st=5zVbaB&reflink=article_copyURL_share

User Image DDiamond_Handz Posted - 1 week ago

$SABS its going to be ok

User Image Realtea03 Posted - 1 week ago

$SABS another couple hundred just to round out my total. Trump winning has been a giant blessing to the numbers on my screen. It would be nice if this ticker starts contributing to that sometime soon.

User Image stockboyaisle1 Posted - 1 week ago

$SABS Thankful for the SAB team for their patience, diligence and commitment!

User Image stockboyaisle1 Posted - 2 weeks ago

$SABS SAB 185 was the last one standing at the end of the COVID trials that started under Trump and Warp Speed. 185 “Trumped” Regeneron against Omicron but the trials were ultimately shut down during the Biden administration. 142 will get us across the finish line.

User Image DDiamond_Handz Posted - 2 weeks ago

$SABS healthy pullback, green tomorrow

User Image Realtea03 Posted - 2 weeks ago

$SABS huh. did not see this coming

User Image Realtea03 Posted - 2 weeks ago

$SABS another big win for me. another 500 shares! crazy volatility lately

User Image Tradethetrend08 Posted - 2 weeks ago

$SABS $10+ by Friday. $DRUG type of run

User Image Tradethetrend08 Posted - 2 weeks ago

$SABS Still in an uptrend don't give up

User Image Michaelsfl Posted - 2 weeks ago

$SABS What's with the warrant price?

User Image Realtea03 Posted - 2 weeks ago

$SABS sorry for the warrant sell volume today I unloaded 30,000 today at or above 7.6 cents. added shares at $4 because I’d rather have shares. holding 5,000 more warrants I will likely keep till they expire.

User Image DDiamond_Handz Posted - 2 weeks ago

$SABS are you ready for it?

User Image Tradethetrend08 Posted - 2 weeks ago

$SABS squeeze it!!

User Image DDiamond_Handz Posted - 2 weeks ago

$SABS its time

User Image Tradethetrend08 Posted - 2 weeks ago

$SABS let's see the run to $10+

User Image SmallCapInfo Posted - 2 weeks ago

$SABS +60% here grinder into data, tells you all you need to know. Loader on 10/16 next target area $5 wonder if they just grind this into end of year towards $10

User Image 2030orbust Posted - 2 weeks ago

@Stocktwits $ASPI $HIMS ; $SABS heating up 🤔 all commons, trading HIMS again for the second time in a month 😭

User Image stockboyaisle1 Posted - 2 weeks ago

$SABS Sooner or later SAB is gonna move so fast no one will be able to hit the buy button fast enough and we will be where Regeneron is today. I believe in SABS.

User Image Realtea03 Posted - 2 weeks ago

$SABS remember anything less than $6 is a deal.

User Image Tradethetrend08 Posted - 2 weeks ago

$SABS can we have a $DRUG type of move to $50? I've been holding sabs for years

User Image 2030orbust Posted - 2 weeks ago

$SABS 👀

User Image Nicks_pics Posted - 2 weeks ago

$SABS Let's do a nice slow grind up to $5.-$7. over the next week or two. Better launch pad altitude for SAB-142 news.

User Image YerOnGuard Posted - 2 weeks ago

$SABS

Analyst Ratings
Oppenheimer Outperform Sep 12, 24
Chardan Capital Buy Sep 9, 24
Oppenheimer Outperform Aug 28, 24
Chardan Capital Buy Aug 12, 24
HC Wainwright & Co. Buy Aug 12, 24
Brookline Capital Buy Jun 7, 24
Chardan Capital Buy May 21, 24
HC Wainwright & Co. Buy May 21, 24
HC Wainwright & Co. Buy Apr 16, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Sullivan Eddie Joe Chief Executive Offi.. Chief Executive Officer Dec 07 Buy 0.88 1,740 1,531 5,232,304 12/08/23
King Michael CHIEF FINANCIAL OFFI.. CHIEF FINANCIAL OFFICER Nov 30 Buy 0.900 5,000 4,500 5,000 11/30/23
HAMILTON CHRISTINE E Director Director Sep 13 Buy 0.7297 10,000 7,297 4,993,090 09/14/22
Sullivan Eddie Joe CHIEF EXECUTIVE OFFI.. CHIEF EXECUTIVE OFFICER Sep 07 Buy 0.7368 14,000 10,315 5,230,564 09/08/22